Cargando…

Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London

OBJECTIVES: We examined the 4 year trend in antimicrobial susceptibilities and prescribing across levels of care at two London teaching hospitals and their multisite renal unit, and for the surrounding community. METHODS: Laboratory and pharmacy information management systems were interrogated, with...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Luke S. P., Freeman, Rachel, Gilchrist, Mark J., Gharbi, Myriam, Brannigan, Eimear T., Donaldson, Hugo, Livermore, David M., Holmes, Alison H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228780/
https://www.ncbi.nlm.nih.gov/pubmed/25118270
http://dx.doi.org/10.1093/jac/dku307
_version_ 1782344043177443328
author Moore, Luke S. P.
Freeman, Rachel
Gilchrist, Mark J.
Gharbi, Myriam
Brannigan, Eimear T.
Donaldson, Hugo
Livermore, David M.
Holmes, Alison H.
author_facet Moore, Luke S. P.
Freeman, Rachel
Gilchrist, Mark J.
Gharbi, Myriam
Brannigan, Eimear T.
Donaldson, Hugo
Livermore, David M.
Holmes, Alison H.
author_sort Moore, Luke S. P.
collection PubMed
description OBJECTIVES: We examined the 4 year trend in antimicrobial susceptibilities and prescribing across levels of care at two London teaching hospitals and their multisite renal unit, and for the surrounding community. METHODS: Laboratory and pharmacy information management systems were interrogated, with antimicrobial use and susceptibilities analysed between hospitals, within hospitals and over time. RESULTS: A total of 108 717 isolates from 71 687 patients were identified, with significant differences (at P < 0.05) in antimicrobial susceptibility between and within hospitals. Across the 4 years, rates of ESBL-/AmpC-producing Enterobacteriaceae ranged from 6.4% to 10.7% among community isolates, 17.8% to 26.9% at ward level and 25.2% to 52.5% in critical care. Significant variations were also demonstrated in glycopeptide-resistant enterococci (ward level 6.2%–17.4%; critical care 21.9%–56.3%), MRSA (ward level 18.5%–38.2%; critical care 12.5%–47.9%) and carbapenem-resistant Pseudomonas spp. (ward level 8.3%–16.9%; critical care 19.9%–53.7%). Few instances of persistently higher resistance were seen between the hospitals in equivalent cohorts, despite persistently higher antimicrobial use in Hospital 1 than Hospital 2. We found significant fluctuations in non-susceptibility year on year across the cohorts, but with few persistent trends. CONCLUSIONS: The marked heterogeneity of antimicrobial susceptibilities between hospitals, within hospitals and over time demands detailed, standardized surveillance and appropriate benchmarking to identify possible drivers and effective interventions. Homogeneous antimicrobial policies are unlikely to continue to be suitable as individual hospitals join hospital networks, and policies should be tailored to local resistance rates, at least at the hospital level, and possibly with finer resolution, particularly for critical care.
format Online
Article
Text
id pubmed-4228780
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-42287802014-11-13 Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London Moore, Luke S. P. Freeman, Rachel Gilchrist, Mark J. Gharbi, Myriam Brannigan, Eimear T. Donaldson, Hugo Livermore, David M. Holmes, Alison H. J Antimicrob Chemother Original Research OBJECTIVES: We examined the 4 year trend in antimicrobial susceptibilities and prescribing across levels of care at two London teaching hospitals and their multisite renal unit, and for the surrounding community. METHODS: Laboratory and pharmacy information management systems were interrogated, with antimicrobial use and susceptibilities analysed between hospitals, within hospitals and over time. RESULTS: A total of 108 717 isolates from 71 687 patients were identified, with significant differences (at P < 0.05) in antimicrobial susceptibility between and within hospitals. Across the 4 years, rates of ESBL-/AmpC-producing Enterobacteriaceae ranged from 6.4% to 10.7% among community isolates, 17.8% to 26.9% at ward level and 25.2% to 52.5% in critical care. Significant variations were also demonstrated in glycopeptide-resistant enterococci (ward level 6.2%–17.4%; critical care 21.9%–56.3%), MRSA (ward level 18.5%–38.2%; critical care 12.5%–47.9%) and carbapenem-resistant Pseudomonas spp. (ward level 8.3%–16.9%; critical care 19.9%–53.7%). Few instances of persistently higher resistance were seen between the hospitals in equivalent cohorts, despite persistently higher antimicrobial use in Hospital 1 than Hospital 2. We found significant fluctuations in non-susceptibility year on year across the cohorts, but with few persistent trends. CONCLUSIONS: The marked heterogeneity of antimicrobial susceptibilities between hospitals, within hospitals and over time demands detailed, standardized surveillance and appropriate benchmarking to identify possible drivers and effective interventions. Homogeneous antimicrobial policies are unlikely to continue to be suitable as individual hospitals join hospital networks, and policies should be tailored to local resistance rates, at least at the hospital level, and possibly with finer resolution, particularly for critical care. Oxford University Press 2014-12 2014-08-12 /pmc/articles/PMC4228780/ /pubmed/25118270 http://dx.doi.org/10.1093/jac/dku307 Text en © The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Research
Moore, Luke S. P.
Freeman, Rachel
Gilchrist, Mark J.
Gharbi, Myriam
Brannigan, Eimear T.
Donaldson, Hugo
Livermore, David M.
Holmes, Alison H.
Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London
title Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London
title_full Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London
title_fullStr Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London
title_full_unstemmed Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London
title_short Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London
title_sort homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in london
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228780/
https://www.ncbi.nlm.nih.gov/pubmed/25118270
http://dx.doi.org/10.1093/jac/dku307
work_keys_str_mv AT moorelukesp homogeneityofantimicrobialpolicyyetheterogeneityofantimicrobialresistanceantimicrobialnonsusceptibilityamong108717clinicalisolatesfromprimarysecondaryandtertiarycarepatientsinlondon
AT freemanrachel homogeneityofantimicrobialpolicyyetheterogeneityofantimicrobialresistanceantimicrobialnonsusceptibilityamong108717clinicalisolatesfromprimarysecondaryandtertiarycarepatientsinlondon
AT gilchristmarkj homogeneityofantimicrobialpolicyyetheterogeneityofantimicrobialresistanceantimicrobialnonsusceptibilityamong108717clinicalisolatesfromprimarysecondaryandtertiarycarepatientsinlondon
AT gharbimyriam homogeneityofantimicrobialpolicyyetheterogeneityofantimicrobialresistanceantimicrobialnonsusceptibilityamong108717clinicalisolatesfromprimarysecondaryandtertiarycarepatientsinlondon
AT branniganeimeart homogeneityofantimicrobialpolicyyetheterogeneityofantimicrobialresistanceantimicrobialnonsusceptibilityamong108717clinicalisolatesfromprimarysecondaryandtertiarycarepatientsinlondon
AT donaldsonhugo homogeneityofantimicrobialpolicyyetheterogeneityofantimicrobialresistanceantimicrobialnonsusceptibilityamong108717clinicalisolatesfromprimarysecondaryandtertiarycarepatientsinlondon
AT livermoredavidm homogeneityofantimicrobialpolicyyetheterogeneityofantimicrobialresistanceantimicrobialnonsusceptibilityamong108717clinicalisolatesfromprimarysecondaryandtertiarycarepatientsinlondon
AT holmesalisonh homogeneityofantimicrobialpolicyyetheterogeneityofantimicrobialresistanceantimicrobialnonsusceptibilityamong108717clinicalisolatesfromprimarysecondaryandtertiarycarepatientsinlondon